Research & Innovation in Anesthesia

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  9 (2024)
Volume  8 (2023)
Volume  7 (2022)
Volume  6 (2021)
Volume  5 (2020)
Volume  4 (2019)
Volume  3 (2018)
Volume  2 (2017)
Volume  1 (2016)
Related articles

VOLUME 8 , ISSUE 2 ( July-December, 2023 ) > List of Articles

CASE REPORT

Inflammatory Fibromyalgia: A Diagnostic Dilemma

Reena Jindal

Keywords : Case report, Creatine phosphokinase, Disease-modifying antirheumatic drugs, Inflammatory fibromyalgia, Polymyositis/Dermatomyositis

Citation Information : Jindal R. Inflammatory Fibromyalgia: A Diagnostic Dilemma. Res Inno Anesth 2023; 8 (2):51-53.

DOI: 10.5005/jp-journals-10049-2032

License: CC BY-NC 4.0

Published Online: 29-12-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Fibromyalgia in many ways remains a challenge for the medical profession. Patients are forced to give up work and become increasingly isolated, misunderstood and frustrated. The etiology and mechanisms of fibromyalgia are not well understood. One of the features distinguishing fibromyalgia from inflammatory conditions is the absence of elevated inflammatory markers. More recently, reports of inflammatory fibromyalgia are increasingly reported where patients have negative rheumatic serology but elevated inflammatory markers. They present a diagnostic dilemma and may receive unnecessary treatment. We aim to highlight association of inflammation and fibromyalgia and emphasize the importance of treating the patient and not focusing exclusively on abnormal laboratory results.

HTML PDF Share
  1. Bergman S, Herrström P, Högström K, et al. Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study. J Rheumatol 2001;28(6):1369–1377.
  2. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain 2011;152(3 Suppl):S2–S15. DOI: 10.1016/j.pain.2010.09.030
  3. Bijlsma J, Hachulla E. EULAR textbook on rheumatic disease. 3rd Ed. London: BMJ publishing group Ltd, 2018.
  4. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA 2004;292(19):2388–2395. DOI: 10.1001/jama.292.19.2388
  5. Häuser W, Walitt B, Fitzcharles MA, et al. Review of pharmacological therapies in fibromyalgia syndrome. Arthritis Res Ther 2014;16(1):201. DOI: 10.1186/ar4441
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.